Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 52N4S | — |
Bexsero - Administration to patient older than 25 years of age; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 31-year-old female patient who received Men B NVS (Bexsero) (batch number 52N4S, expiry date 30-NOV-2027) for prophylaxis. On 22-JAN-2025, the patient received Bexsero. On 22-JAN-2025, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Bexsero - Administration to patient older than 25 years of age). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-APR-2025 The nurse reported that the administration of Bexsero to a female patient 31 year old and the vaccine was administered by mistake. The nurse asked for safety information. The patient received a dose of Bexsero at an inappropriate age, which led to inappropriate age at vaccine administration.